Niu, W.Y., Wan, Y.G., Li, M.Y., Wu, Z.X., Zhang, L.G. and Wang, J.X. (2013) The Diagnostic Value of Serum Procalcitonin, IL-10 and C-Reactive Protein in Community Acquired Pneumonia and Tuberculosis. European Review for Medical and Pharmacological Sciences, 17, 3329-3333.

has been cited by the following article:

• TITLE: Procalcitonin—A Useful Biomarker for Pneumonia Associated with Rhodococcus equi?

  AUTHORS: Ann Kristin Barton, Martin Rieger, Dana Teschner, Heidrun Gehlen

  KEYWORDS: Foal, Horse, Lung, Pneumonia, Procalcitonin, Rhodococcus equi

  JOURNAL NAME: Modern Research in Inflammation, Vol.5 No.2, May 11, 2016

  ABSTRACT: Background: Procalcitonin, a precursor protein of the hormone calcitonin, is a sensitive marker for sepsis in human medicine, which is used for diagnosis of bacterial pneumonia in adults and neonates to initiate antibiotic therapy. Objectives: In this study, procalcitonin was evaluated as a potential biomarker for Rhodococcus equi associated pneumonia. Methods: In four foals procalcitonin was measured at four time-points (day 0 before antibiotic therapy, day 1, 3 and 5/6 during therapy) in plasma using an equine specific ELISA. Inclusion criteria for the study were a positive sepsis score, ultrasonographic evidence of pulmonary abscesses in addition >8 cm, a positive microbiology out of tracheobronchial secretion and positive response to antibiotic treatment (azithromycin 10 mg/kg BDW 24q PO and rifampicin 10 mg/kg BDW 12q PO) within a weak including improvement of clinical status and reduction of ultrasonographic score Rhodococcus equi.